TGen-Led Team Prepares to Validate 'TARDIS' Blood-Based Cancer Monitoring Method

Aug 09, 2019

|

Premium

NEW YORK – Investigators from TGen, working with City of Hope, Mayo Clinic, and other clinical collaborators, are gearing up to clinically validate and prove utility for their liquid biopsy method to monitor patients with early-stage cancer as they are treated, allowing doctors to better predict if they need additional interventions or may be effectively cured.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

Recent Headlines from
Precision Oncology News

The Scan

PLOS Papers Describe Preconception Carrier Screening, Bacterial Virulence Features, More

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Sharing the Clinical Data

Canadian regulators are beginning to share information from new drug studies, Undark reports.

And Now the Environment's Role

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Possibly Heart-Stopping

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Oct

24

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Menu